Austin W. Marxe & David M. Greenhouse’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-33,139	Closed	-$1.5M	–	147
2013 Q2	$1.5M	Buy	+33,139	New	+$1.5M	0.2%	100

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LBH

Lehman Brothers Holdings New York $794K AUM 28.79% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's KBIO Position: Q3 2013 in Review

Austin W. Marxe & David M. Greenhouse sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2013, closing a stake of 33,139 shares — an estimated $1.5M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in KBIO in Q2 2013 and held it in 1 quarter. The position peaked at $1.5M in Q2 2013. 50 funds tracked by Wall St. Rank hold KBIO as of Q3 2013.

Austin W. Marxe & David M. Greenhouse reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2013 after selling out during the quarter.
Austin W. Marxe & David M. Greenhouse sold 33,139 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2013, an estimated $1.5M.
Austin W. Marxe & David M. Greenhouse first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 1 quarter.
Austin W. Marxe & David M. Greenhouse's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $1.5M in Q2 2013.
50 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2013.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2013, filed 8 Nov 2013.